Events

Cannabis Health Confirms Curaleaf Laboratories as London Symposium Headline Sponsor for Second Year Running

Curaleaf Laboratories renews its headline sponsorship of the Cannabis Health Symposium: London, having also backed the event’s inaugural edition in 2025. Cannabis Health, the clinical education platform powered by Prohibition […]

Sponsored features editor

Curaleaf Laboratories renews its headline sponsorship of the Cannabis Health Symposium: London, having also backed the event’s inaugural edition in 2025.

Cannabis Health, the clinical education platform powered by Prohibition Partners, today announced that Curaleaf Laboratories will return as headline sponsor of the Cannabis Health Symposium: London, taking place on Thursday 26 November 2026 at Conway Hall, London. 

The sponsorship marks the second consecutive year Curaleaf Laboratories has backed the event and committed to clinician education, having also served as headline sponsor when the Symposium launched in London last year. 

The Cannabis Health Symposium: London is a full-day event bringing together clinicians, prescribers, healthcare professionals, industry leaders and patient advocates for evidence-based education on medical cannabis. The 2026 agenda covers topics such as the regulation of unlicensed cannabis-based medicines, NHS prescribing pathways, building safe and compliant medical cannabis services, workplace considerations, mental health care, clinical trials, women’s health, and neurodiversity. 

Confirmed speakers include Professor David Nutt (Imperial College London, Drug Science), Alex Fraser (Patient Protect), Richard List (Association of Police Controlled Drug Liaison Officers) and Dr Shanna Marrinan (4C Labs), with further additions to the programme to be announced. CPD accreditation is pending, subject to final approval of the programme.

“Supporting the Cannabis Health Symposium for a second year is a natural continuation of our dedication to education. As demand for cannabis-based medicines continues to grow across the UK, it’s vital that healthcare professionals have access to trusted, evidence-based resources so they can support their patients with confidence. We’re committed to amplifying this work through the launch of our free, CPD-accredited Curaleaf Education platform, alongside continued support for initiatives like the symposium.” – Jonathan Hodgson, Managing Director, Curaleaf Laboratories

“The Cannabis Health Symposium bridges the gap between rapidly growing patient demand and the limited medical education available on cannabis based medicines. Curaleaf’s continued support helps healthcare professionals from across the clinical community access the evidence and practical knowledge needed to provide patients with the best possible care.” – Stephen Murphy, CEO, Prohibition Partners

The inaugural Cannabis Health Symposium: London took place at Conway Hall in November 2025, also headline sponsored by Curaleaf Laboratories, and brought together clinicians and industry stakeholders to explore the evolving landscape of medical cannabis prescribing in the UK. This year’s event builds on that foundation with an expanded agenda and speaker line-up.

Early Bird tickets for the Cannabis Health Symposium: London are available now until midnight BST on 4th September, with concession tickets offered to verified healthcare professionals by application. Full programme details and registration are available at cannabishealthnews.co.uk.

Also this autumn: Cannabis Health Symposium: Frankfurt

London is one of two stops in Cannabis Health’s 2026 European Symposium series. The Cannabis Health Symposium: Frankfurt takes place on Wednesday 4 November 2026 at Mainhaus, Frankfurt, focusing on German medical cannabis regulation, patient access and reimbursement through statutory health insurance, alongside clinical sessions on cannabinoid-based pain management and safe prescribing. Curaleaf Laboratories is not a sponsor of the Frankfurt edition. Tickets and full details for both events are available at cannabishealthnews.co.uk/events.